← All candidates
82 insider filings on record.
82 filings on record.
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSE · Healthcare · $13.14B
$272.88
-0.08% · Sep 15
82 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 14 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$13.14B
Float
47.2M
98% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
21.5
Price / sales
3.3
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
77 more transactions on Pro →Context
Wall St
$228.50 avg target
-16.3% vs today · 14 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$2.06 act+$0.11
Q4 '25$2.39 act+$0.04
Q3 '25$2.43 act+$0.09
Q2 '25$3.12 act+$0.57
Coverage
Charles River Prepares to Report Q2 Earnings: What's in Store?Zacks · 07-30Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks · 07-29Charles River Laboratories Earnings Preview: What to ExpectBarchart · 07-20What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?Zacks · 07-17
The file stays open
82 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice